Next Article in Journal
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
Next Article in Special Issue
Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation–Processing Aspects and Challenges
Previous Article in Journal
Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy
Previous Article in Special Issue
Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations
 
 
Article

Article Versions Notes

Pharmaceutics 2018, 10(2), 64; https://doi.org/10.3390/pharmaceutics10020064
Action Date Notes Link
article xml file uploaded 26 May 2018 10:50 CEST Original file -
article pdf uploaded. 26 May 2018 10:50 CEST Version of Record https://www.mdpi.com/1999-4923/10/2/64/pdf-vor
article supplementary file uploaded. 26 May 2018 10:50 CEST - https://www.mdpi.com/1999-4923/10/2/64#supplementary
article xml file uploaded 26 May 2018 11:49 CEST Update -
article xml uploaded. 26 May 2018 11:49 CEST Update https://www.mdpi.com/1999-4923/10/2/64/xml
article pdf uploaded. 26 May 2018 11:49 CEST Updated version of record https://www.mdpi.com/1999-4923/10/2/64/pdf
article supplementary file uploaded. 26 May 2018 11:49 CEST - https://www.mdpi.com/1999-4923/10/2/64#supplementary
article html file updated 26 May 2018 11:50 CEST Original file -
article html file updated 27 June 2018 13:52 CEST Update -
article html file updated 30 March 2019 04:55 CET Update -
article html file updated 16 April 2019 16:51 CEST Update -
article html file updated 30 April 2019 16:23 CEST Update -
article html file updated 3 October 2019 23:58 CEST Update -
article html file updated 9 February 2020 19:10 CET Update https://www.mdpi.com/1999-4923/10/2/64/html
Back to TopTop